Lipomas of the Oral Cavity: Utility of MDM2 and CDK4 in Avoiding Overdiagnosis as Atypical Lipomatous Tumor

被引:15
|
作者
Stojanov, Ivan J. [1 ,2 ]
Marino-Enriquez, Adrian [3 ,4 ]
Bahri, Nacef [3 ,4 ]
Jo, Vickie Y. [3 ,4 ]
Woo, Sook-Bin [5 ,6 ]
机构
[1] Case Western Reserve Univ, Sch Dent Med, Dept Oral & Maxillofacial Med & Diagnost Sci, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA
[3] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA
[4] Harvard Med Sch, Boston, MA 02115 USA
[5] Harvard Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA USA
[6] StrataDx, Ctr Oral Pathol, Lexington, MA USA
来源
HEAD & NECK PATHOLOGY | 2019年 / 13卷 / 02期
关键词
Lipoma; Atypical lipomatous tumor; Liposarcoma; Well-differentiated liposarcoma; Immunohistochemistry; FISH; WELL-DIFFERENTIATED LIPOSARCOMA; ANISOMETRIC CELL LIPOMA; GENE; EXPRESSION; NEOPLASMS; DIAGNOSIS; SUBTYPES; REGION;
D O I
10.1007/s12105-018-0928-0
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Traumatized lipomas with degenerative change may demonstrate histopathologic features that mimic atypical lipomatous tumor (ALT). Previously reported series of ALT involving the oral cavity preceded routine use of MDM2 and CDK4 immunohistochemistry. Our aim is to evaluate MDM2 and CDK4 immunohistochemical expression in adipocytic tumors arising in this site, in conjunction with the histiocytic marker PU.1, to determine whether MDM2 and CDK4 impacts classification. 17 cases originally diagnosed as ALT were retrieved and immunohistochemical studies for MDM2, CDK4 and PU.1 were performed. FISH analysis for MDM2 amplification was performed in select cases. For this study group, the male:female ratio was 9:8 and the median age was 62 (range 41-88). All 17 cases presented as well- or predominantly well-circumscribed proliferations of variably sized, mature adipocytes exhibiting uni- or multi-vacuolation with occasional scalloped nuclei and mild nuclear atypia. Variable amounts of fibrous stroma with focal myxoid change and bland spindle cells were identified in 14/17 cases. Lipoblasts or atypical hyperchromatic stromal cells were not identified in any cases. 14 of 17 cases were negative for MDM2 and CDK4 in tumor cells and 11 of these 14 showed weak nuclear positivity for MDM2 in histiocytes. 3 of 17 cases showed weak, multifocal immunohistochemical expression of MDM2 and CDK4. PU.1 highlighted histiocytes in all 17 cases. FISH analysis for MDM2 amplification was negative in all 3 cases with weak MDM2/CDK4 expression. All cases were reclassified as lipoma with degenerative changes. ALT, in all likelihood, is less common than previously thought in this anatomic location and best diagnosed with ancillary studies. MDM2 expression in histiocytes is best interpreted in conjunction with CDK4 immunohistochemistry and confirmatory FISH for MDM2 amplification.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 50 条
  • [21] MDM2 and CDK4 Are Coexpressed in a Subset of Extraskeletal Osteosarcoma
    Yoshida, A.
    Ushiku, T.
    Motoi, T.
    Fukayama, M.
    Tsuda, H.
    Shibata, T.
    MODERN PATHOLOGY, 2011, 24 : 24A - 24A
  • [22] MDM2 and CDK4 Coexpression Is Uncommon in Sarcomatoid Carcinomas
    Sukeda, A.
    Yoshida, A.
    Yoshida, M.
    Tsuta, K.
    Kushima, R.
    Tsuda, H.
    LABORATORY INVESTIGATION, 2013, 93 : 21A - 22A
  • [23] Amplification of CDK4 and MDM2 is associated with atypical clinical features in high risk neuroblastoma patients
    Fransson, Susanne M.
    Kryh, Hanna
    Javanmardi, Niloufar
    Ambros, Inge M.
    Berbegall, Ana P.
    Ora, Ingrid
    Noguera, Rosa
    Asmundsson, Jurate
    Sandstedt, Bengt
    Ambros, Peter F.
    Kogner, Per
    Martinsson, Tommy
    CANCER RESEARCH, 2016, 76
  • [24] MDM2/CDK4 gene amplification in large/deep-seated 'lipomas': incidence, predictors and clinical significance
    Wong, Daniel D.
    Low, Irene C.
    Peverall, Joanne
    Robbins, Peter D.
    Spagnolo, Dominic V.
    Nairn, Robert
    Carey-Smith, Richard L.
    Wood, David
    PATHOLOGY, 2016, 48 (03) : 203 - 209
  • [25] Nonsystemic amplification of MYC with CDK4 and MDM2 in a malignant mixed tumor of salivary gland
    Rao, PH
    Murty, VVVS
    Louie, DC
    Chaganti, RSK
    CANCER GENETICS AND CYTOGENETICS, 1998, 105 (02) : 160 - 163
  • [26] COAMPLIFICATION OF THE CDK4 GENE WITH MDM2 AND GLI IN HUMAN SARCOMAS
    KHATIB, ZA
    MATSUSHIME, H
    VALENTINE, M
    SHAPIRO, DN
    SHERR, CJ
    LOOK, AT
    CANCER RESEARCH, 1993, 53 (22) : 5535 - 5541
  • [27] Reproducibility of MDM2 and CDK4 staining in soft tissue tumors
    Binh, MBN
    Garau, XS
    Guillou, L
    Aurias, A
    Coindre, JM
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 125 (05) : 693 - 697
  • [28] Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas
    Laroche-Clary, Audrey
    Chaire, Vanessa
    Algeo, Marie-Paule
    Derieppe, Marie-Alix
    Loarer, Francois L.
    Italiano, Antoine
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [29] MDM2 Gene Amplification and Expression of MDM2 and CDK4 are Rare in Ossifying Fibroma of Craniofacial Bones
    Bahceci, Dorukhan H.
    Jordan, Richard C. K.
    Horvai, Andrew E.
    HEAD & NECK PATHOLOGY, 2022, 16 (04): : 991 - 997
  • [30] Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas
    Audrey Laroche-Clary
    Vanessa Chaire
    Marie-Paule Algeo
    Marie-Alix Derieppe
    François L. Loarer
    Antoine Italiano
    Journal of Hematology & Oncology, 10